Center for Preclinical Trials and SITNO Pharma signed a cooperation agreement

| By | Clinical Trials, Drug Development

Center for Preclinical Trials LLC, a specialized organization of “PharmDolina”, the Pharmaceutical Cluster of the Cluster Consortium of the Moscow Region, and European pharmaceutical company SITNO Pharma signed the Agreement on Cooperation and Protection of Clients.

The Agreement provides for conducting in vivo and in vitro preclinical studies and testing of agrochemicals, chemicals, bactericides, medical devices, pharmaceuticals, etc., as well as the provision of other services for pharmaceutical, chemical, agrochemical and biotech industries on the sites of the Cluster.

Professor Arkady Murashev, the Chairman of the Board of PharmDolina Cluster and the Head of the Biological Testing Laboratory at the Branch of the Institute of Bioorganic Chemistry of the Russian Academy of Sciences, said that the preclinical trials conducted in the laboratory meet all international standards, and the results of the trials can be used for registering the Russian medical and pharmaceutical developments in the countries of the Organization for Economic Cooperation and Development and the United States.

Mr. Ludovit Černak, CEO and Managing Director of Sitno Pharma a.s., who initiated the cooperation on the European side, noted high quality standards in preclinical trials and great potential of companies for cooperation in the area of bioscreening, in vitro and in vivo trials, and other services for pharmaceutical, chemical, agrochemical, and biotech industries.

GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.